The information was formerly published in GEX document number 100-101 and 100-256
Incoming B3 dosimeter product stock assessment
A protocol must be established for the purchase, receipt, acceptance and storage of dosimeters. See also Use Case Qualification.
Receipt of B3 Dosimeter Product
|
Inspect product box(es) for visible damage |
Product is shipped in cardboard boxes designed to withstand the duration of expected travel. Inspect all packages upon receipt and report any damage or discrepancies to GEX with photographs. |
|
Inspect irreversible temperature labels |
GEX includes irreversible temperature monitoring labels inside every cardboard box in a shipment of dosimeter products to monitor maximum temperature in transit for informational purposes only. See Storage. |
|
Maintain storage conditions |
See B3 dosimeter product Storage. |
Inspection and Testing
Users must verify the dosimeter response or performance before use.
|
User responsibility |
Users must test new stock of B3 dosimeter product and verify the B3 dosimeter response before use. Users should treat each shipment as a separate stock unless they can be demonstrated to be equivalent. |
|
Industry guidance |
ASTM 51275 |
|
GEX guidance |
Dosimeter Stock Receiving Inspection Procedure - describes GEX recommended practices for the receipt and inspection of GEX B3 Dosimeter shipments. |
Disclaimer - The information contained in this document is provided “as is” and is not a substitute for the user’s professional judgement. It is provided as a convenience to those using products provided by GEX Corporation who have sufficient technical skills to evaluate and properly apply the information in this document. It is the responsibility of the user of this document to ensure that the information in this document, and the use of such information, is accurate, complete, applicable to the product, suitable for the user’s purposes, and in compliance with all laws and regulations. GEX Corporation believes the information provided in this document is accurate and reliable as of the time of writing, but it undertakes no obligation to update or correct this document. GEX Corporation may, but is not required to, make changes to this document at any time without notice. By using the information in this document, the user represents and warrants that he or she has the skills necessary to properly understand and apply this information and that he or she will comply with all applicable laws and regulations including, without limitation, those relating to medical devices, pharmaceutical products, or other applicable industries. The user assumes all risks associated with using this information and any results or output resulting from the application of this information to GEX Corporation’s products. The user agrees not to hold GEX Corporation liable for any errors or omissions contained within.